Hirsch Andrew
SEC CIK 1586707 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Pres, CEO, Dir | 1.07M | $84.0K | — | 19 | 2022-04-12 | 2026-02-14 |
Most active insiders at CCCC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | REYNO LEONARD | Chief Medical Off | — | $22.2K |
| 2 | Mahaney Paige | CSO | — | — |
| 3 | Mossler Mark | CAO | — | — |
| 4 | Adams Kendra | CFO | — | — |
| 5 | Boyle Scott N | Chief Business Off | — | — |
| 6 | Anderson Kenneth Carl | Dir | — | — |
| 7 | Schick Kelly | CHRO | — | — |
| 8 | GROGAN DONNA ROY | Dir | — | — |
| 9 | Hirsch Andrew | Pres, CEO, Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-18 | 2026-02-14+ | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $1.89 | -48.2K | 1.07M | -4% | -$91.1K |
| 2026-02-18 | 2026-02-13 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | A - Grant | $0.00 | +700.0K | 1.12M | +165% | $0 | |
| M | 2026-02-18 | 2026-02-14+ | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | $0.00 | +102.1K | 1.08M | +10% | $0 |
| D | 2025-02-18 | 2025-02-14 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | A - Grant | $0.00 | +223.5K | 445.4K | +101% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $3.18 | -22.2K | 432.5K | -5% | -$70.7K |
| D | 2024-11-12 | 2024-11-07 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $6.04 | -5,550 | 221.9K | -2% | -$33.5K |
| D | 2024-11-12 | 2024-11-07 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | — | +12.5K | 227.4K | +6% | — |
| D | 2024-09-17 | 2024-09-16 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $6.36 | -3,329 | 214.9K | -2% | -$21.2K |
| D | 2024-09-17 | 2024-09-16 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | — | +7,500 | 218.2K | +4% | — |
| D | 2024-02-15 | 2024-02-14 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | A - Grant | $0.00 | +103.4K | 217.3K | +91% | $0 |
| 2024-02-15 | 2024-02-15 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $7.90 | -6,560 | 210.7K | -3% | -$51.8K | |
| D | 2023-08-31 | 2023-08-30 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | — | +7,500 | 116.1K | +7% | — |
| D | 2023-08-31 | 2023-08-30 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $2.93 | -2,205 | 113.9K | -2% | -$6,461 |
| D | 2023-02-15 | 2023-02-15 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | A - Grant | $0.00 | +81.6K | 108.6K | +302% | $0 |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $7.78 | -4,319 | 27.0K | -14% | -$33.6K |
| D | 2023-02-01 | 2023-01-30 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | — | +12.5K | 31.3K | +66% | — |
| A | 2022-06-14 | 2022-05-26 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | F - Tax | $7.01 | -3,675 | 18.8K | -16% | -$25.8K |
| D | 2022-05-27 | 2022-05-25 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | M - OptEx | — | +12.5K | 22.5K | +125% | — |
| 2022-04-12 | 2022-04-12 | CCCC | C4 Therapeutics, Inc. | Hirsch Andrew | Pres, CEO, Dir | P - Purchase | $8.40 | +10.0K | 10.0K | New | +$84.0K |
Purchase Sale Sale after option exercise All abbreviations